← 產業報告目錄
Sterile Injectable Contract Manufacturing Market Size, Share & Trends Analysis Distribution by Molecules Type (Biologics, Small molecules), Therapeutic Applications (Cancer, Diabetes, Cardiovascular Disease, Neurological Disorders, Infectious Disorders, Musculoskeletal Disorders), Route of Administration (Subcutaneous, Intravenous, Intramuscular), End Users (Pharmaceutical & Biopharmaceutical Companies) and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-23頁數 180報告編號 INSIGHTACE-10e57f603c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Sterile Injectable Contract Manufacturing Market on a global scale was estimated at USD 13.1 Bn in 2023 and is projected to attain USD 22.9 Bn by 2031, with a projected CAGR of 7.5% between 2024 and 2031.
Sterile Injectable Contract Manufacturing covers reshaping how healthcare entities approach this space.
Market momentum is fueled by expanding need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Sterile Injectable Contract Manufacturing Market Snapshot
Chapter 4. Global Sterile Injectable Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Molecules Type Estimates & Trend Analysis
5.1. by Molecules Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Molecules Type:
5.2.1. Biologics
5.2.2. Small molecules
Chapter 6. Market Segmentation 2: by Therapeutic Applications Estimates & Trend Analysis
6.1. by Therapeutic Applications & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapeutic Applications:
6.2.1. Diabetes
6.2.2. Cardiovascular Disease
6.2.3. Neurological Disorders
6.2.4. Infectious Disorders
6.2.5. Musculoskeletal Disorders
6.2.6. Others
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
7.2.1. Subcutaneous
7.2.2. Intravenous
7.2.3. Intramuscular
7.2.4. Others
Chapter 8. Market Segmentation 4: by End Users Estimates & Trend Analysis
8.1. by End Users & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End Users:
8.2.1. Pharmaceutical Companies
8.2.2. Biopharmaceutical Companies
8.2.3. Others
Chapter 9. Sterile Injectable Contract Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Molecules Type, 2023-2031
9.1.2. North America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Applications, 2023-2031
9.1.3. North America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
9.1.4. North America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
9.1.5. North America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.2. Europe
9.2.1. Europe Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Molecules Type, 2023-2031
9.2.2. Europe Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Applications, 2023-2031
9.2.3. Europe Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
9.2.4. Europe Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
9.2.5. Europe Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Molecules Type, 2023-2031
9.3.2. Asia Pacific Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Applications, 2023-2031
9.3.3. Asia-Pacific Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
9.3.4. Asia-Pacific Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
9.3.5. Asia Pacific Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.4. Latin America
9.4.1. Latin America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Molecules Type, 2023-2031
9.4.2. Latin America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Applications, 2023-2031
9.4.3. Latin America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
9.4.4. Latin America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
9.4.5. Latin America Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Molecules Type, 2023-2031
9.5.2. Middle East & Africa Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Applications, 2023-2031
9.5.3. Middle East & Africa Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
9.5.4. Middle East & Africa Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2023-2031
9.5.5. Middle East & Africa Sterile Injectable Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Aenova Group
10.2.2. Baxter
10.2.3. Boehringer Ingelheim
10.2.4. Catalent
10.2.5. Cipla
10.2.6. Fresenius Kabi
10.2.7. Famar
10.2.8. Grifols
10.2.9. NextPharma Technologies
10.2.10. Recipharm
10.2.11. Unither Pharmaceuticals
10.2.12. Vetter Pharma
10.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們